Organigram Holdings Inc. Repayment/Issuance of Debt (Net)

Repayment/Issuance of Debt (Net) of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Repayment/Issuance of Debt (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Repayment/Issuance of Debt (Net) for the quarter ending May 31, 2022 was $-11 Thousand (a -33.33% decrease compared to previous quarter)
  • Year-over-year quarterly Repayment/Issuance of Debt (Net) decreased by -30.55%
  • Annual Repayment/Issuance of Debt (Net) for 2021 was $-91.3 Million (a -286.22% decrease from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2020 was $49 Million (a 41.24% increase from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2019 was $34.7 Million (a -72.66% decrease from previous year)
  • Twelve month Repayment/Issuance of Debt (Net) ending May 31, 2022 was $-59.8 Thousand (a -99.88% decrease compared to previous quarter)
  • Twelve month trailing Repayment/Issuance of Debt (Net) decreased by -99.94% year-over-year
Trailing Repayment/Issuance of Debt (Net) for the last four month:
31 May '22 28 Feb '22 30 Nov '21 31 Aug '21
$-59.8 Thousand $-48.4 Million $-93 Million $-93.3 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Repayment/Issuance of Debt (Net) of Organigram Holdings Inc.

Most recent Repayment/Issuance of Debt (Net)of OGI including historical data for past 10 years.

Interactive Chart of Repayment/Issuance of Debt (Net) of Organigram Holdings Inc.

Organigram Holdings Inc. Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.01 $-0.02
2021 $-0.02 $-0.02 $-48.36 $-44.63 $-91.32
2020 $-0.24 $23.01 $-2.15 $-0.0 $49.04
2019 $26.27 $0.41 $27.18 $-0.21 $34.72
2018 $7.45 $89.88 $127.01
2017 $-1.4
2016 $2.0

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic